Note T - Subsequent Events	12 Months Ended
Dec. 31, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE T—SUBSEQUENT EVENTS On January 8, 2025, the Company issued 14,970 shares of common stock in repayment of $25,000 of the principal due on the 2024 Note. On January 10, 2025, 679 shares of restricted common stock were forfeited by employees who left the Company before the lapse of the restriction period applicable to such shares. On January 10, 2025, 5,000 shares of restricted common stock were forfeited by employees who left the Company before the lapse of the restriction period applicable to such shares. On January 15, 2025, the Company entered into a warrant exercise agreement under which the counterparty agreed to exercise outstanding warrants to purchase 2,061,112 shares of common stock at an exercise price of $1.85 per share resulting in gross proceeds of approximately $3.8 million, prior to deducting placement agent fees and estimated offering expenses. In connection with this transaction, the Company issued additional warrants to purchase an aggregate 3,091,668 shares of common stock at an exercise price of $2.15 per share. On January 15, 2025, the Company issued 149,635 shares of common stock in repayment of $205,000 of the principal due on the 2024 Note. On January 15, 2025, the Company issued 340,000 shares of common stock in repayment of $629,000 of the principal due on the 2024 Note. On January 17, 2025, the Company issued 431,000 shares of common stock upon the exercise of warrants. On January 23, 2025, the Company issued 427,112 shares of common stock upon the exercise of warrants. On February 14, 2025, the Company issued 241,000 shares of common stock upon the exercise of warrants. On March 13, 2025, the Company issued 491,000 shares of common stock upon the exercise of warrants. On March 20, 2025, the Company issued 8,913 shares of common stock to its directors in payment of board fees. On March 20, 2025, the Company issued 2,500 shares of restricted stock to new employees which vest over three-years. The forgoing issuances of common stock after December 31, 2024 total 2,106,130 shares representing a 56% increase in the Company's outstanding shares of common stock since December 31, 2024, less forfeitures. On March 28, 2025, 1,893 shares of restricted common stock were forfeited by an employee who left the Company before the lapse of the restriction period applicable to such shares.

Note T - Subsequent Events

12 Months Ended

Dec. 31, 2024

NOTE T—SUBSEQUENT EVENTS

On January 8, 2025, the Company issued 14,970 shares of common stock in repayment of $25,000 of the principal due on the 2024 Note.

On January 10, 2025, 679 shares of restricted common stock were forfeited by employees who left the Company before the lapse of the restriction period applicable to such shares.

On January 10, 2025, 5,000 shares of restricted common stock were forfeited by employees who left the Company before the lapse of the restriction period applicable to such shares.

On January 15, 2025, the Company entered into a warrant exercise agreement under which the counterparty agreed to exercise outstanding warrants to purchase 2,061,112 shares of common stock at an exercise price of $1.85 per share resulting in gross proceeds of approximately $3.8 million, prior to deducting placement agent fees and estimated offering expenses. In connection with this transaction, the Company issued additional warrants to purchase an aggregate 3,091,668 shares of common stock at an exercise price of $2.15 per share.

On January 15, 2025, the Company issued 149,635 shares of common stock in repayment of $205,000 of the principal due on the 2024 Note.

On January 15, 2025, the Company issued 340,000 shares of common stock in repayment of $629,000 of the principal due on the 2024 Note.

On January 17, 2025, the Company issued 431,000 shares of common stock upon the exercise of warrants.

On January 23, 2025, the Company issued 427,112 shares of common stock upon the exercise of warrants.

On February 14, 2025, the Company issued 241,000 shares of common stock upon the exercise of warrants.

On March 13, 2025, the Company issued 491,000 shares of common stock upon the exercise of warrants.

On March 20, 2025, the Company issued 8,913 shares of common stock to its directors in payment of board fees.

On March 20, 2025, the Company issued 2,500 shares of restricted stock to new employees which vest over three-years.

The forgoing issuances of common stock after December 31, 2024 total 2,106,130 shares representing a 56% increase in the Company's outstanding shares of common stock since December 31, 2024, less forfeitures.

On March 28, 2025, 1,893 shares of restricted common stock were forfeited by an employee who left the Company before the lapse of the restriction period applicable to such shares.